https://youtu.be/H_RititNE8U

Contravisory Investment Management Inc. increased its position in shares of Moderna, Inc. (NASDAQ: M

MRNA keeps its 2026 growth target intact while cutting cost guidance and advancing flu, oncology and

Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes

The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first

Moderna (MRNA) stock made a name for itself during the height of the pandemic, trading as high as $4

The U.S. Food and Drug Administration (FDA) on Wednesday approved Moderna Inc.'s (NASDAQ:MRNA) mFLUS

Moderna receives FDA approval for mFLUSIVA, a new seasonal flu vaccine for adults 50 and older, laun

Moderna Inc (NASDAQ:MRNA) is up 3.6% at $58.30 ahead of the open, after the U.S. Food and Drug Admin

Moderna's mRNA-based flu vaccine, mFlusiva, is approved by the Food and Drug Administration for adul

Memory stocks falter after guidance from Sandisk and Western Digital fails to meet the market's sky-

"Flu remains a significant public health challenge, and mFLUSIVA provides an important new option fo

The decision caps a seven-month review that included a rare refusal to consider the shot at all.

The U.S. Food and Drug Administration has approved Moderna's flu vaccine for people aged 50 and olde

mFLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved product Company e

Moderna starts Phase 1 trials for Ebola vaccine mRNA-1469. See premarket MRNA stock reaction, analys

Cetera Investment Advisers boosted its position in shares of Moderna, Inc. (NASDAQ: MRNA) by 28.1% d

Moderna's vaccine candidate targets a species of ebolavirus behind a deadly outbreak in the Democrat

Moderna on Tuesday said it has begun its first human trial of an experimental vaccine to protect aga

Moderna, Inc. (NASDAQ:MRNA) today announced that following Health Canada's authorization of the

Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no l

Citigroup analyst Geoff Meacham maintains Moderna (NASDAQ:MRNA) with a Neutral and raises the pri

Moderna's Q2 revenue tops estimates, but shares fall after its phase III norovirus vaccine study mis

Moderna, Inc. (MRNA) Q2 2026 Earnings Call Transcript

Moderna (MRNA) Q2 Earnings: Beat estimates with $145M in sales and a $1.97 EPS loss. Reaffirms 2026

Moderna is navigating a post-COVID transition, shifting focus to a diversified vaccine and therapeut

Moderna (NASDAQ:MRNA) affirms FY2026 sales outlook from $2.138 billion to $2.138 billion vs $2.089 b

Goldman Sachs analyst Salveen Richter maintains Moderna (NASDAQ:MRNA) with a Neutral and raises t

Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first U.S. participant in its Phase 1

Intel stock has more than doubled this year, but JPMorgan has named the chipmaker one of its highest

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Rivian Automotive Inc (RIVN) gained 12.2% after strong Q2 production figures and raised delivery for

Capricor stock falls after the FDA schedules a July advisory committee meeting for Deramiocel, its D

Semiconductors cratered Friday, dragging the stock market lower, while health care and software led

Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected f

Financials and utilities led Wall Street higher Tuesday as oil slid toward $77 and investors brace f

https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/

https://www.cdc.gov/ebola/situation-summary/index.html

Moderna and Novavax stocks climb as investors digest new cases in the hantavirus outbreak.

DGXX up 19.5% in pre-market trading after increasing the offering program. EZGO, HPAI, MRAM, NVEC,

https://www.nytimes.com/2026/05/05/us/politics/fda-covid-vaccine-studies.html

Moderna stock rises after EU approval of flu-COVID combo vaccine mCOMBRIAX, backed by Phase 3 data s

FDA court freeze leaves COVID, flu, RSV vaccines in limbo as Kennedy's ACIP overhaul faces legal

Trump, in January, said "inflation has been defeated." Wall Street is now bracing for a 0.9%

Wall Street analysts changed outlook on top names. See complete view of rating changes, including up

Medicare Chief Chris Klomp is optimistic for strong outcome in the search of CDC leader in midst of

A federal judge warns that RFK Jr.'s vaccine overhaul likely violates federal law. Discover the

FDA biologics chief Vinay Prasad will leave in April, lifting biotech stocks such as uniQure, Capric